Lyme Disease References And Useful Web Links


Accepting New Patients Today, Call (202) 955-0003

Lyme Disease References And Useful Web Links

For More Information:

The Internet can be an ideal place to find additional information on Lyme disease and other vector borne diseases.

Photo References:


    1. Derdakova M, Beati L, Pet’Ko B, Stanko M, Fish D. (2003) Genetic variability within Borrelia burgdorferi sensu lato genospecies established by PCR – single strand conformation polymorphism analysis of the rrfa-rr1b intergenic spacer in Ixodes ricinus ticks from the Czech Republic. Appl. Environ. Microbiol. Jan; 69(1): 509-16.
    2. Seinost G, Golde WT, Berger BW, Dunn JJ, Qui D, Dunkin DS, Dykhuisen De, Luft BJ, Dattwyler RJ. (1999) Infection with multiple strains of Borrelia sensu stricto in patients with Lyme disease. Arch. Dermatol. 135:1329-1333.
    3. Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang I, Wormser GP, Schriefer ME, Luft BJ. (1999) Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Inf and Immun 67(7):3518-3524.
    4. Picken RN, Strle F, Picken MM, Ruzic-Sablijic E, Maraspin V, Lotric-Furlan S, Cimperman J. (1998) Indentification of three species of Borrelia burgdorferi senso lato (B burgdorferi senso stricto, B garinii, and B afzelii) among isolates from acrodermatitis chronicus atrophicans lesions. J. Investig. Dermatol. 110:211-214.
    5. Postic D, Assous MV, Grimont PAD, Baranton G. (1994) Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf 5S – rrl 23S intergenic amplicons. Int J. Syst. Bacteriol. 44:743-752.
    6. Valsangiacomo C, Balmelli T, Piffaretti JC. (1997) A phylogentic analysis of Borrelia burgdorferi sensu lato based on sequence information from the hbb gene, coding for a histone- like protein. Int. J. Syst. Bacteriol. 47: 1-10.
    7. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PAD. (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42:378-383.
    8. Steere AC, Malawista SE, Snydman DR et al (1977) Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arth Rheum. 20:7-17).
    9. Steere AC. (1989) Lyme disease. N Engl J Med. 321:586-96
    10. Weber K, et al (1984) Erythema Migrans disease and related disorders. Yale J Biol Med 57:13-21
    11. Azlehus A. (1921) Erthema Chronicum Migrans. Acta Derm Vernereol 2:120-125
    12. Garun, B. (1922) Paralysie par les tiques. J Med Lyon71:765-767
    13. Bannwarth A. (1941) Chronisch lymphocytare meningitis, entzundliche polyneuritis and rheumtisums. Arch Psychiatr Nervenkr 113:284-376
    14. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. (1982) Lyme Disease: a tick-borne spirochetosis? Science. 216:1317-9.
    15. Barbour AG, Hayes SF. Biology of Borrelia species. (1986) Microbiol Rev 50:381-400.
    16. Fraser CM, Casjens S, Huang WM, et al. (1997) Genomic sequence of a Lyme disease spirochete, Borrleia burgdorferi. Nature. 390:580-6.
    17. TBA
    18. Vanderhoof-Forschner, K (1997) Everything You Need to Know About Lyme Disease New York: John Wiley & Sons.
    19. Garcia-Monco JC, Fernandez – Villar B, Benach JL. (1989) Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis. 160:497-506.
    20. Halperin, J (2000) Nervous system Lyme disease. Infect Med, 17:556-560.
    21. Coyle P, Deng Z, Schutzer S, Belman A, Benach J, Krupp L, Luft B. (1993) Detection of Borrelia burgdorferi antigens in cerebrospinal fluid. Neurology. 43:1093-1097.
    22. Leigner KB. Evidence for borrelial etiology and pathogenesis in a series of patients carrying a diagnosis of Multiple Sclerosis [abstract] 45th International Northwestern Conference on Diseases in Nature Communicable to Man. Vancouver, Britich Columbia, August , 1992.
    23. Leigner KB. Difficulty of distinction between borrelial (Lyme) encephalomyelitis and Multiple Sclerosis [abstract] 45th International Northwestern Conference on Diseases in Nature Communicable to Man. Vancouver, BritiSh Columbia, August , 1992.
    24. de Vignes F, Piesman J, Heffernan R, Schulze TL, Stafford KC, Fish D. (2001)Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymph. J Infect Dis. 183(5): 773-8.
    25. TBA
    26. TBA
    27. LoGiudice K, Ostfeld RS, Schmidt KA, Kersing F. (2003) The ecology of infectious disease: Effects of host diversity and community composition on Lyme disease risk. Proc. Nat Acad Sci. USA, Jan 13.
    28. TBA
    29. Thompson C, Spielman A, Krause PJ. (2001) Co-infecting deer-associated zoonoses: Lyme Disease, Babesiosis and Ehrlichiosis. Clin Inf Dis. 33(5): 676-85
    30. Thomas V, Anguita J, Barthold SW, Fikrig E. (2001)Co-infection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine responses, pathogen burden and severity of Lyme arthritis. Infect Immun 69(5):3359-71.
    31. Krause RT, Lepore T, Sikand VK, Gadbaw J, Burke G, Telford SR, Blassard P, Pearl D, Azlanzadeh J, Christianson P, McGrath D, Spielman A. (2000) Babesia treatment with atovaquone and azithromycin. N Eng J Med 343(20): 1454 – 58.
    32. Krause PJ, Telford SR, Spielman A, Sikand V, Ryan R, Christiansono D et al. (1996) Concurrent Lyme disease and Babesiosis: Evidence for increased severity and duration of illness. JAMA. 275: 1657 – 60.
    33. Krause PJ, Spielman A, Telford SR, Sikand V, McKAy K, Christianson D, Pollack RJ, Brassard P, Mayera J, Ryan R, Persing D. (1998) Persistent parasitemia after acute babesiosis. N End J Med. 339:160 -5.
    34. Olano JP, Walker DH. (2002) Human Ehrlichiosis: diagnostic challenges and therapeutic recommendations. Infect Med. 19:318 – 325.
    35. Persing DH, Conrad PA. (1995) Babesiosis: New insights form phylogenetic analysis. Infect Agents and Dis. 4(4):182-195.
    36. CDC. Lyme Disease – United States, 1999, MMWR. 16 March 2001;50(10): 181-185.
    37. Stafford K. Community programs: new technologies in tick control. Program and abstracts of the 14th International Scientific Conference on Lyme Disease and Other Tick – Borne Disorders; April 21-23, 2001; Hartford, Connecticut.
    38. Rawlings J, Mocharnuk R. An Ounce of Prevention. Program and abstracts of the 14th International Scientific Conference on Lyme Disease and Other Tick – Borne Disorders; April 21-23, 2001; Hartford, Connecticut.
    39. Bosler EM. Host-targeted acaricidal treatments on rodents to control densities of Ixodes scapularis subadult ticks. Program and abstracts of the 14th International Scientific Conference on Lyme Disease and Other Tick – Borne Disorders; April 21-23, 2001; Hartford, Connecticut.
    40. Gardner T. (1995) Lyme Disease. Infectious Diseases of the Fetus and Newborn. New York, NY: Remington – Saunders 447-528.
    41. TBA
    42. Burkot TR, Mullen GR, Anderson R, Schneider BS, Happ CM, Zeidner NS. (2001) Borrelia lonestari DNA in adult Amblyomma americanum ticks, Alabama. CDC, 7(3), May -June.
    43. Fallon B, Mocharnuk R. Tick – borne and other emerging infectious diseases. Program and abstracts of the 14th International Scientific Conference on Lyme Disease and Other Tick – Borne Disorders; April 21-23, 2001; Hartford, Connecticut.
    44. Masters E. Girardeau C.(1998) Erythema migrans in the south. Arch Int Med 158: 2162-2165.
    45. Masters E. Babesiosis, ehrlichiosis, Lyme-like disease variations. Program and abstracts of the 14th International Scientific Conference on Lyme Disease and Other Tick – Borne Disorders; April 21-23, 2001; Hartford, Connecticut.
    46. Masters E, Donnell D (1995) Lyme and/or Lyme-like disease in Missouri. Miss Med. 92(7):346-353.
    47. Kirkland KB, Klimko TB, Meriwether RA, Schriefer M, Levin M, Levine J, MacKenzie WR, Dennis DT (1997) Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Arch Intern Med. 157(22):2635-41.
    48. TBA
    49. TBA
    50. TBA
    51. TBA
    52. Steere A, Malawista S, Hardin J et al. (1977) Erythema chronicum migrans and Lyme arthritis: The enlarging clinical spectrum. Ann Intern Med 86:685 – 698.
    53. Donta S. (2002) Late and Chronic Lyme Disease. Med Clin N Amer. 86(2):341-49.
    54. Telford Sr, Lepore TJ, Snow P, Warner CK, Dawson JE. (1995) Human granulocytic ehrlichiosis in Massachusetts. Ann Intern Med 123:277 -279.
    55. Westerman EL (1982) Rocky Mountain Spotless Fever: a dilemma for the clinician. Arch Intern Med 142:439 – 48.
    56. Sexton DJ, Covey GR (1992) Rocky Mountain spotless fever and almost spotless fever: a wolf in sheep’s clothing. Clin Inf Dis 15:439-48.
    57. Kawabata H, Masuzawa T, Yanagihara Y. (1993) Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovalus in Japan. Microbiol Immunol. 37:843-848.
    58. Postic D, Ras NM, Lane RS, Hendson M, Baranton G. (1998) Expanded diversity among Californian Borrelia isolates and description of Borrelia bissellii sp. nov. (Formerly Borrelia Group DN117). J Clin Microbiiol 36:3497-3504.
    59. Balmelli T, Piffaretti JC (1996) Analysis of the genetic polymorphism of Borrelia burgdorferi senso lato by multilocus enzyme electrophoresis. Int J Syst Bacteriol 46:167-172.
    60. Preac-Mursic V, Wilske B, Schierz G, Holmburger M, Sub E (1987) In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur J Clin Microbiol6(4): 424-426.
    61. Preac-Mursic V, Marget W, Busch U, Rigler P, Hagl S. (1996) Kill kinetics of borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme Borreliosis. Infection 24 (1):9-16.
    62. Sartakova ML, Dobrikova EY, Terekhova DA, Devis R, Bugrysheva JV, Morozova OV, Godfrey HP, Cabello FC. (2003) Novel antibiotic-resistance markers in pGK12-derived vectors for Borrelia burgdorferi. Gene. 303(1-2): 131-137.
    63. TBA
    64. Preac – Mursic V, Wanner G, Reinhardt S, Wilse B, Busch V, Marget W. (1996) Formation and cultivation of Borrelia burgdorferi spheroplast L-form variants. Infection. 24:218-226.
    65. TBA
    66. Fife WP, Freeman A (1998) treatment of Lyme disease with hyperbaric oxygen therapy[abstract 75]. Underseas and Hyperbaric Medicine. 1998; 25 (supplement): Porgram and abstracts of the Undersea and Hyperbaric Medical Society Annual Scientific Meeting. May 19-26, 1998. Seattle, WA.
    67. Guttman D, Wang G, Wang I-N, Bosler E, Luft B, Dykhuisen D. (1996) Mulitiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as reavealed by single-strand conformation polymorphism analysis. J Clin Microbiol. 34(3): 652-656.
    68. TBA
    69. Montgomery R, Nathanson M, Malawista S (1991) Intracellular fate of Borrleia burgdorferi in mouse macrophages. Arth Rheum. Vol 34, 350.
    70. Georgilis K, Peacocke M, Klempner MS (1992) Fibroblasts protect the spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 166:440-444.
    71. Klempner MS, Noring R, Rogers RA (1993) Invasion of human skin fibroblasts by the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis 167:1074-1081.
    72. TBA
    73. TBA
    74. Stricker RB, Burrascano JJ, Winger EE (2002) Long term decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann Agricult Environ Med. 9:111-113.
    75. Stricker RB, Winger EE. Normalization of the CD 57 natural killer-cell subset associated with prolonged antibiotic therapy in patients with chronic Lyme disease [abstract 357] FOCIS 2nd Annual Meeting.
    76. Talkington J, Nickell S. (1999) Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun. 67(3): 1107-1115.
    77. Straubinger RK, Straubinger AF, Summers BA, Erb HN, Harter L, Appel MJ (1998) Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures. Infect Immun. 66(1):247-258.
    78. Ma Y, Weis JJ ((1993) Outer surface lipoproteins OspA and OSP B posess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun. 61:3843-3853.
    79. Kasley A, Anguita J, Marriott I (2002) Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol. 130(1-2):22-31.
    80. Mandell GL, Bennett JE, Dolin R (Ed.) (1995) Mandell, Douglas and Bennett’s Principles and Practices of Infectious Diseases, Fourth Edition,p102-149.
    81. Levy JA. (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. Mar 57(1):183-289.
    82. Parren PW, Moore JP, Burton DR, Sattentau QJ (1999) The neutralizing antibody response to HIV -1:viral evasion and escape from humoral immunity. AIDS 13 supplA;S137-62.
    83. Butera ST, Roberts BD, Lam L et al (1994) Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Viriol 68:2726-2730.
    84. Philips RE, Rowland-Jones S, Nixon DF, eta l (1991) Human immunodeficiency virus that can escape cytotoxic T cell recognition. Nature 354:453-459.
    85. Roberts Ed, Bohn RP, Lowrie RC, eta l (1998) Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis. 178:722-32.
    86. Cadavid D, O’Neill T, Schaefer H, Pachner AR (2000) Localization of Borrelia burgdorferi in the nervous system and other organs in a non-human primate model of Lyme disease. Lab Iinvest. 80:1043-54.
    87. TBA
    88. Lorenzi MC, Bittar RS, Pedalini ME, Zerati F, Yoshinari NH, Bento RF (2003) Sudden deafness and Lyme disease. Laryngoscope. 113(2):312-5.
    89. Stricker RB, Winger EE (2001) Holmes-Adie Syndrome and Lyme Disease. Lancet. 357:805.
    90. Logigian EL, Kaplan RF, Steere AC. (1990) Chronic neurologic manifestations of Lyme Disease. N Engl J Med. 323:1438-1444.
    91. Pachner AR, Steere AC (1985) The triad of neurological manifestations of lyme disease meningitis, cranial neuritis and radiculoneuritis. Neur. 35:47-5333.
    92. Fallon B, Nields JA, Burrascano J, Leigner K, DelBene D, Liebowitz M (1992) The neuropsychiatric manifestations of Lyme Borreliosis. Psych Quart. 63(1), Spring.
    93. Tager FA, Fallon BA, Keilp J, Rissenberg M, Kones CR, Leibowitz MR (2001) Acontrolled study of cognitive defecits in children with chronic Lyme Disease. J Neuropsych Clin Neuroscience. 13:500-507.
    94. Halperin JJ (2000) Nervous system Lyme disease. Inf Med.17:556-560.
    95. Fallon B, Goldhagen H (2002) Neurologic Lyme disease: Defining an elusive target. 14th International Conference on Lyme Disease and other Tick -borne Disorders, April 21-23, 2002.
    96. Reznick JW, Braunstein DM, Walsh RI, Smith CR, Wolfson PM, Gierke IW, Gorelkin I, Chandler RW (1986) Lyme carditis. Electrophysiologic and histopathologic study. Am J Med. 5:923-927.
    97. Stanek G, Klein J, Bittner R, Glogan D (1990) Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med. 322:249-252.
    98. Keszler K. (2002) Cardiac Manifestations of Lyme Disease. Programmed abstracts of the 14th International Conference on Lyme Disease and other Tick-borne Disorders. April 21-23, 2002.
    99. Asbrink E, Hovmark A (1985) Successful cultivation of spirochetes from skin lesions of patients with erythema chronicus migrans Afzelius and acrodermatitis chronica atrophicans. Acta Pathol Micobiol Immunol Scand [B]. 93:161-3.
    100. Scrimenti R. (1995) Acrodermatits chronica atrophicans: Historical and clinical overview. J Spirochetal Tick-borne Dis. 2(4):97-100.
    101. Gass, JDM(1968) Acute posterior multifocal pigment epitheliopathy. Arch Ophthalmol 1968;80:177-185.
    102. Durani, K (1999)Acute Posterior Mulifocal Placoid Pigment Epitheliopathy, case report and clinical review. MEEI Immunology Service.
    103. Deutman AF, Lion F(1977)Choriocapillaris non-perfusion in acute posterior multifocal placoid pigment epitheliopathy. Am J Opthalmol. 84: 45-49.
    104. Wolf, MD, Folk JC, Pankene CA, Goeken EN (1990) HLA B7 and HLA DR2 antigens and acute placoid multifocal pigment epitheliopathy. Arch Ophthalmol.108:698-700.
    105. Steere, AC, Dwyer E, Winchester R (1990) Arthritis with HLA-DR4 and HLA-DR2 alleses. NEJM 323:219-223.
    106. TBA
    107. Morrison, DC, The effects of bacterial endotoxins on host mediation systems. Amer Jrnl Path 93: 526, 1978.
    108. Herxheimer, K. Krause. “Uber eine bei Syphilitische vorkommende Quecksilerberreaktion. Deutsch. Med. Wschr.28:50, 1902.
    109. Herxheimer, K. and Martin, H: So-called Herxheimer reactions. Arch Derm Syph 13:115, 1926.
    110. Fleischman, K., and Kreibich, C: Zum Wesen der Reaktion nach Jarisch-Herxheimer. Me. Klin. 21:1157, 1925.
    111. Jadassohn, J: Beitrab zur Jarisch-Herxheimer Reaktion. Z Haut Geschlechtskr 19: 158, 1965.
    112. Mahoney, J.F., Arnold, R.C., and Harris, A: Penicillin and the Jarisch-Herxheimer reaction in early, cardiovascular and neurosyphilis. Amer J Public Health 33: 1387, 1943.
    113. Primary author unknown: The Herxheimer Effect, Supplement to the Art of Getting Well. The Arthritis Trust of America: 370, 1991.
    114. Gudjonsson, Haraldur: The Jarisch-Herxheimer Reaction, Stockholm 1972. A summary based on seven publications).
    115. Dinarello, CA, Cannon JG, Wolff SM, Tumor necrosis factor is an endogenous pyrogen and induces production of interleukin-1. J Exp Med. 1986; 163: 1433-1450).
    116. Burrascano, JJ: The new Lyme disease: diagnostic hints and treatment guidelines for tick-borne illnesses.
    117. Personal letter from Russ McMillan, D.D.S., M.P.H., Dr. P.H. to The Arthritis Trust of America/The Rheumatoid Disease Foundation, June 13, 1994.
    118. TBA
    119. Oski J, Nikoskelainen J, Viljanen MK 91998) Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 17:715-19.
    120. Nadelman RB, Nowakowski J, Fish D, Falco R, Freemann K, McKenna D, Welch P, Marcus R, Aquero-Rosenfeld M, Dennis D, Wormser G (2001) Prophylaxis with single dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 345.
    121. Klempner, Hu, Evans, et al.(2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 345.
    122. Brorson O, Brorson SH (1997) Tansformation of cystic forms of Borrelia burgdorferi to mobile spirochetes. Inf 25:240-246.
    123. Kersten A, Poitschek C, Rauch S, Aberer E. Effect of penicillin, ceftriaxone and doxycycline on morphology of Borrelia burgdorferi. Antimicrobial Agents Chem. 39(5)1127-33.
    124. Brorson O, Brorson SH (date) An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. APMIS. 107(6): 566-576.
    125. TBA
    126. TBA
    127. TBA
    128. TBA
    129. TBA
    130. TBA
    131. TBA
    132. Donta S (2001) Reactivation of Lyme Disease following Lyme OspA vaccine. Program and abstracts of the 14th International Scientific Conference on Lyme Disease and Other Tick-borne Disorders. April 21-23, 2001.
    133. Fawcett PT, Rose CD, Budd SM et al (2001) Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Clin Diagn Lab Immunol. 8:79-84.
    134. TBA
    135. Sigal LH.(2002) Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology. Ann Int Med. 136:413-19.
    136. Steere AC (2001) Lyme Disease. N Engl J Med July, 2001
    137. Stricker RB (2001) Lyme Disease: Empiricism and Irrationalism. Editorial. Submitted to NEJM but rejected for publication.
    138. TBA
    139. Preac-Mursic (1984)
    140. Preac-Mursic (1985)
    141. Silverman ME, Murray TJ, Bryan CS. Ed. (2003) The Quotable Osler. Philadelphia: ACP-ASIM

Table of Contents

  • Contact Us

  • This field is for validation purposes and should be left unchanged.